{"id":2395,"date":"2023-03-08T08:48:25","date_gmt":"2023-03-08T08:48:25","guid":{"rendered":"https:\/\/exemfoamdev.resetwebstudio.nl\/nalevingsprogramma"},"modified":"2023-03-30T11:37:35","modified_gmt":"2023-03-30T11:37:35","slug":"nalevingsprogramma","status":"publish","type":"page","link":"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma","title":{"rendered":"Nalevingsprogramma"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2395\" class=\"elementor elementor-2395 elementor-1602\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ffe45ba elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"ffe45ba\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-dc40085\" data-id=\"dc40085\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f569dd1 elementor-widget elementor-widget-heading\" data-id=\"f569dd1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">ExEm Foam Inc.  <\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-10cc657 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"10cc657\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-85e8fbe\" data-id=\"85e8fbe\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-642b3cc elementor-widget elementor-widget-heading\" data-id=\"642b3cc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">Alomvattend nalevingsprogramma van Californi\u00eb<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a5004c0 elementor-widget elementor-widget-text-editor\" data-id=\"a5004c0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span data-fusion-font=\"true\">ExEm Foam Inc. zet zich in om een effectief nalevingsprogramma op te zetten en te onderhouden in overeenstemming met de Compliance Program Guidance gepubliceerd door het U.S. Department of Health and Human Services, Office of Inspector General1 (de &#8220;OIG Guidance&#8221;). Verder heeft de gezondheidszorgindustrie de PhRMA Code on Interactions with Health Care Professionals (PhRMA)2 opgesteld, en het Comprehensive Compliance Program van ExEm Foam Inc. is ontworpen in overeenstemming met deze code. In overeenstemming met de vrijwillige normen die door de OIG Guidance zijn vastgesteld en zoals uitdrukkelijk erkend in de OIG Guidance, hebben wij ons Compliance Program aangepast aan de unieke omgeving en omvang van ExEm Foam Inc. Wij herzien ons Compliance Programma regelmatig om te voldoen aan de veranderende richtlijnen van de industrie en de compliance behoeften van ons bedrijf.<\/span><br \/><span data-fusion-font=\"true\"><br \/>\u200d<\/span><br \/><span data-fusion-font=\"true\"><br \/>Ons Compliance Programma dat door onze Raad van Bestuur is opgesteld, is bedoeld om overtredingen van de wet of het beleid van ExEm Foam Inc. te voorkomen en op te sporen; zoals in de OIG Guidance wordt erkend, kan de implementatie van een Compliance Programma echter niet garanderen dat onbehoorlijk gedrag volledig wordt uitgebannen. ExEm Foam Inc. verwacht dat werknemers en onze vertegenwoordigers zich houden aan ons beleid inzake interacties met HCP&#8217;s en de andere beleidslijnen die zijn opgesteld ter ondersteuning van ons Compliance Programma. In het geval dat ExEm Foam Inc. zich bewust wordt van mogelijke schendingen van de wet of het bedrijfsbeleid, zal het bedrijf de zaak onderzoeken en relevante disciplinaire maatregelen nemen en corrigerende maatregelen treffen om toekomstige schendingen te voorkomen.<\/span><br \/><span data-fusion-font=\"true\"><br \/>\u200d<\/span><br \/><span data-fusion-font=\"true\"><br \/>Zoals vereist door de California Health &amp; Safety Code \u00a7119402(d) heeft ExEm Foam Inc. een jaarlijkse uitgavenlimiet van $2.000 ge\u00efmplementeerd voor educatieve artikelen, promotieartikelen of activiteiten die ExEm Foam Inc. mag verstrekken aan erkende professionals in de gezondheidszorg in Californi\u00eb. Deze promotionele artikelen en activiteiten zijn ook onderworpen aan beperkingen die zijn uiteengezet in ons beleid inzake interacties met HCP&#8217;s (in overeenstemming met de PhRMA Code) en andere beleidslijnen en procedures van het Compliance Program.<\/span><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-358f187 elementor-widget elementor-widget-heading\" data-id=\"358f187\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Company, Inc. 2021 Verklaring van overeenstemming<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-69c8901 elementor-widget elementor-widget-text-editor\" data-id=\"69c8901\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>ExEm Foam Inc. verklaart hierbij dat zij naar beste weten en overtuiging haar Comprehensive Compliance Program en de relevante vereisten van California Health &amp; Safety Code \u00a7\u00a7119400-119402 naleeft.<\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e4eda47 elementor-widget elementor-widget-heading\" data-id=\"e4eda47\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Contactgegevens<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9a09266 elementor-widget elementor-widget-text-editor\" data-id=\"9a09266\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span data-fusion-font=\"true\">Voor een kopie van deze verklaring of voor meer informatie over ons nalevingsprogramma kunt u contact opnemen met ExEm Foam Inc. door een e-mail te sturen naar <\/span><a class=\"in-text-link\" href=\"mailto:compliance@exem-foam.com\" data-uw-styling-context=\"true\" data-uw-rm-brl=\"exc\" aria-label=\"send an email to compliance@exem-foam.com \" data-uw-rm-vglnk=\"\" data-fusion-font=\"true\">compliance@exem-foam.com<\/a><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-173e916 elementor-widget elementor-widget-text-editor\" data-id=\"173e916\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p class=\"paragraph\" data-uw-styling-context=\"true\"><span class=\"target space\" data-uw-styling-context=\"true\" data-fusion-font=\"true\">1 <\/span><span data-fusion-font=\"true\">Compliance Program Guidance for Pharmaceutical Manufacturers.<\/span><\/p>\n<div class=\"c-citations-container\">\n<p><span class=\"target space\" data-uw-styling-context=\"true\" data-fusion-font=\"true\">2 <\/span><a class=\"in-text-link\" href=\"https:\/\/www.phrma.org\/en\/Codes-and-guidelines\/Code-on-Interactions-with-Health-Care-Professionals\" target=\"_blank\" rel=\"noopener\" data-uw-styling-context=\"true\" data-uw-rm-brl=\"false\" aria-label=\"https:\/\/www.phrma.org\/en\/Codes-and-guidelines\/Code-on-Interactions-with-Health-Care-Professionals - opens in new tab\" data-uw-rm-ext-link=\"\" data-fusion-font=\"true\">https:\/\/www.phrma.org\/en\/Codes-and-guidelines\/Code-on-Interactions-with-Health-Care-Professionals<\/a><\/p>\n<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>ExEm Foam Inc. Alomvattend nalevingsprogramma van Californi\u00eb ExEm Foam Inc. zet zich in om een effectief nalevingsprogramma op te zetten en te onderhouden in overeenstemming met de Compliance Program Guidance gepubliceerd door het U.S. Department of Health and Human Services, Office of Inspector General1 (de &#8220;OIG Guidance&#8221;). Verder heeft de gezondheidszorgindustrie de PhRMA Code on [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2395","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nalevingsprogramma - Exemfoam<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nalevingsprogramma - Exemfoam\" \/>\n<meta property=\"og:description\" content=\"ExEm Foam Inc. Alomvattend nalevingsprogramma van Californi\u00eb ExEm Foam Inc. zet zich in om een effectief nalevingsprogramma op te zetten en te onderhouden in overeenstemming met de Compliance Program Guidance gepubliceerd door het U.S. Department of Health and Human Services, Office of Inspector General1 (de &#8220;OIG Guidance&#8221;). Verder heeft de gezondheidszorgindustrie de PhRMA Code on [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma\" \/>\n<meta property=\"og:site_name\" content=\"Exemfoam\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-30T11:37:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl\\\/nalevingsprogramma\",\"url\":\"https:\\\/\\\/exemfoam.eu\\\/nl\\\/nalevingsprogramma\",\"name\":\"Nalevingsprogramma - Exemfoam\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl#website\"},\"datePublished\":\"2023-03-08T08:48:25+00:00\",\"dateModified\":\"2023-03-30T11:37:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl\\\/nalevingsprogramma#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/exemfoam.eu\\\/nl\\\/nalevingsprogramma\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl\\\/nalevingsprogramma#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/exemfoam.eu\\\/nl\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nalevingsprogramma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl#website\",\"url\":\"https:\\\/\\\/exemfoam.eu\\\/nl\",\"name\":\"Exemfoam\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/exemfoam.eu\\\/nl?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl#organization\",\"name\":\"Exemfoam\",\"url\":\"https:\\\/\\\/exemfoam.eu\\\/nl\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/exemfoam.eu\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/Logo.png\",\"contentUrl\":\"https:\\\/\\\/exemfoam.eu\\\/wp-content\\\/uploads\\\/2023\\\/01\\\/Logo.png\",\"width\":205,\"height\":42,\"caption\":\"Exemfoam\"},\"image\":{\"@id\":\"https:\\\/\\\/exemfoam.eu\\\/nl#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nalevingsprogramma - Exemfoam","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma","og_locale":"nl_NL","og_type":"article","og_title":"Nalevingsprogramma - Exemfoam","og_description":"ExEm Foam Inc. Alomvattend nalevingsprogramma van Californi\u00eb ExEm Foam Inc. zet zich in om een effectief nalevingsprogramma op te zetten en te onderhouden in overeenstemming met de Compliance Program Guidance gepubliceerd door het U.S. Department of Health and Human Services, Office of Inspector General1 (de &#8220;OIG Guidance&#8221;). Verder heeft de gezondheidszorgindustrie de PhRMA Code on [&hellip;]","og_url":"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma","og_site_name":"Exemfoam","article_modified_time":"2023-03-30T11:37:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma","url":"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma","name":"Nalevingsprogramma - Exemfoam","isPartOf":{"@id":"https:\/\/exemfoam.eu\/nl#website"},"datePublished":"2023-03-08T08:48:25+00:00","dateModified":"2023-03-30T11:37:35+00:00","breadcrumb":{"@id":"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/exemfoam.eu\/nl\/nalevingsprogramma"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/exemfoam.eu\/nl\/nalevingsprogramma#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/exemfoam.eu\/nl"},{"@type":"ListItem","position":2,"name":"Nalevingsprogramma"}]},{"@type":"WebSite","@id":"https:\/\/exemfoam.eu\/nl#website","url":"https:\/\/exemfoam.eu\/nl","name":"Exemfoam","description":"","publisher":{"@id":"https:\/\/exemfoam.eu\/nl#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/exemfoam.eu\/nl?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/exemfoam.eu\/nl#organization","name":"Exemfoam","url":"https:\/\/exemfoam.eu\/nl","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/exemfoam.eu\/nl#\/schema\/logo\/image\/","url":"https:\/\/exemfoam.eu\/wp-content\/uploads\/2023\/01\/Logo.png","contentUrl":"https:\/\/exemfoam.eu\/wp-content\/uploads\/2023\/01\/Logo.png","width":205,"height":42,"caption":"Exemfoam"},"image":{"@id":"https:\/\/exemfoam.eu\/nl#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/pages\/2395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/comments?post=2395"}],"version-history":[{"count":2,"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/pages\/2395\/revisions"}],"predecessor-version":[{"id":2403,"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/pages\/2395\/revisions\/2403"}],"wp:attachment":[{"href":"https:\/\/exemfoam.eu\/nl\/wp-json\/wp\/v2\/media?parent=2395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}